A genomic approach to improve prognosis and predict therapeutic response in chronic lymphocytic leukemia. [electronic resource]
Producer: 20100322Description: 6947-55 p. digitalISSN:- 1557-3265
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- pharmacology
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Agents -- pharmacology
- Chlorambucil -- pharmacology
- Cyclophosphamide -- pharmacology
- Disease Progression
- Female
- Gene Expression Profiling
- Gene Expression Regulation, Neoplastic
- Genomics -- methods
- Humans
- Immunotherapy -- methods
- Leukemia, Lymphocytic, Chronic, B-Cell -- genetics
- Male
- Middle Aged
- Pentostatin -- pharmacology
- Pharmacogenetics -- methods
- Prognosis
- Risk
- Rituximab
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.